Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients

Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients

Abstract Purpose Corticosteroids, in particular dexamethasone, are one of the primary treatment options for critically ill COVID-19 patients. However, there are a growing number of cases that involve COVID-19-associated pulmonary aspergillosis (CAPA), and it is unclear whether dexamethasone represen...

Full description

Bibliographic Details
Main Authors: Rasmus Leistner, Lisa Schroeter, Thomas Adam, Denis Poddubnyy, Miriam Stegemann, Britta Siegmund, Friederike Maechler, Christine Geffers, Frank Schwab, Petra Gastmeier, Sascha Treskatsch, Stefan Angermair, Thomas Schneider
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Critical Care
Subjects:
COVID-19
Pulmonary aspergillosis
CAPA
Dexamethasone
Corticosteroid
Online Access:https://doi.org/10.1186/s13054-022-03902-8

Internet

https://doi.org/10.1186/s13054-022-03902-8

Similar Items